Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice

Quan-Wen Liu,Yan-Min Ying,Jia-Xin Zhou,Wen-Jie Zhang,Zhao-xiao Liu,Bing-Bing Jia,Hao-Cheng Gu,Chu-Yu Zhao,Xiao-Hui Guan,Ke-Yu Deng,Hong-Bo Xin
DOI: https://doi.org/10.1186/s13287-022-02906-z
2022-06-04
Abstract:Liver fibrosis is an outcome of restoring process in chronic liver injury. Human amniotic mesenchymal stem cells (hAMSCs) derived from amniotic membrane have multilineage differentiation, immunosuppressive, and anti-inflammatory potential which makes them suitable for treating liver fibrosis. This study aimed to explore the effect and mechanism of hAMSCs on liver fibrosis.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?